Clinical trial
Chemotherapy in Treating Patients With Advanced Kidney Cancer
NCT00011973 · Barbara Ann Karmanos Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00011973 |
|---|---|
| Title | Chemotherapy in Treating Patients With Advanced Kidney Cancer |
| Official title | A Phase Two Study Of Fenretinide In Renal Cell Cancer |
| Lead sponsor | Barbara Ann Karmanos Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Cancer |
| Intervention type | Drug |
| Interventions | fenretinide |
| Start date | Dec 1, 2000 |
| Primary completion | Oct 1, 2005 |
| Completion | Oct 1, 2005 |
| First posted | Aug 8, 2003 |
| Last update posted | Apr 5, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: